Acute Decompensated Heart Failure:
Exciting New Treatment Options
Please read through the following information and click on a profession below.


**This program is an online version of a live webcast. If you participated in the corresponding live activity that occurred in January of 2004, you are not eligible to receive credit for this online program.**

CME Information

Release Date: February 16, 2004
Expiration Date: February 16, 2007

Target Audience
This activity has been designed to meet the educational needs of physicians, nurses and pharmacists.

Educational Objectives
Upon completion of this activity, participants should be better able to:

Program Overview
Today, there are nearly five million Americans living with Congestive Heart Failure (CHF). Heart Failure is the single most expensive diagnosis in the Medicare patient population and is the cause of more hospitalizations in the elderly than any other condition. Accurate diagnosis and expeditious, goal-directed treatment of Acute Decompensated Heart Failure (ADHF) is critical for optimal outcomes.

Faculty
W. Franklin Peacock, IV, MD, FACEP
Director of Clinical Operations
Department of Emergency Medicine
The Cleveland Clinic Foundation
Cleveland, Ohio

Faculty Disclosure
It is the policy of the CE providers to ensure balance, independence, objectivity and scientific rigor in all of their continuing education programs. Faculty must disclose to program participants any significant relationships with companies that manufacture or market products discussed during their presentation. Dr. Peacock has disclosed that he has served as a consultant and speaker for Scios and has received research support for Scios.

Please note: The opinions expressed in this program should not be construed as those of the CE providers. The information and views are those of the faculty through clinical practice and professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

Accreditation
Physicians
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of ACCESS Medical Group and ProCE, Inc. ACCESS Medical Group is accredited by the ACCME to provide continuing medical education (CME) for physicians. ACCESS Medical Group designates this CME activity as meeting the criteria for a maximum of 1.0 hours in category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Nurses
Wild Iris Medical Education, WSNA CEARP Provider number PA-5/Feb/08, is an approved provider of continuing education by the Washington State Nurses Association, an accredited approver by the American Nurses' Credentialing Center's Commission on Accreditation. California BRN Provider #12300. Nurses must submit their license number for credit.

Pharmacists
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Program Number 221-000-04-013-H01 has been assigned to this archived program (initial release date 02-16-04). This program is acceptable for 1.0 contact hours (0.10 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Statements of credit will be issued within 6 weeks of program completion.

Software Requirements
Internet Explorer (v5.5 or greater)
Netscape (v6.1 or greater)
Adobe Acrobat Reader (Required for printable slides and evaluation)
800 x 600 monitor resolution (1024 x 768 recommended)

This program has been funded through an unrestricted educational grant from Scios, Inc.